October 19, 2022
Therapixel announces launch of prospective study on the utility of Artificial Intelligence (AI) as part of second reading breast cancer screening mammograms
The first French prospective clinical study to evaluate the contribution of AI in the second reading of screening mammograms.
0 Comments8 Minutes
May 14, 2022
Therapixel releases a new version of MammoScreen® that leverages prior exams for better accuracy
For the first time, an AI-based decision support software for breast cancer detection uses patient’s prior exams to refine its prediction of malignancy
0 Comments4 Minutes
May 12, 2022
Therapixel announces close of 15 M€ series B financing to deploy MammoScreen® 2D/3D
The Company will accelerate the commercial deployment of its Artificial Intelligence reading solution for 2D/3D mammography, with a focus on the United States
0 Comments11 Minutes
November 28, 2021
Therapixel receives FDA clearance for use of its AI-based breast cancer screening software MammoScreen® on Digital Breast Tomosynthesis
AI-powered reading aid for screening 2D & 3D mammography improves Radiologists’ performance in cancer detection
0 Comments4 Minutes
February 25, 2021
Therapixel will be showcasing MammoScreen™ at the virtual ECR 2021
Stop by our booth to learn more about our FDA-cleared and newly CE-marked AI for breast cancer screening
0 Comments1 Minutes
January 12, 2021
Therapixel receives the CE mark for its Artificial Intelligence-based software (AI) MammoScreen™
This cutting-edge technology assists radiologists in the interpretation of screening mammograms and allows them to diagnose breast cancer earlier and more accurately.
0 Comments3 Minutes
October 16, 2020
Therapixel and RAD-AID International Announce Breast Imaging AI Collaboration for Global Health
The collaboration donates and supports AI for making breast cancer screening more accessible and available in impoverished regions of the world
0 Comments5 Minutes
September 22, 2020
Therapixel participates in the Journées Francophones de Radiologie 2020
Experience the Award-winning MammoScreen™ at our virtual booth on the online platform JFR.plus
0 Comments2 Minutes
September 16, 2020
Therapixel is now ISO/IEC 27001 certified
Our information security management system is compliant with the world gold standard, ensuring a high level of cybersecurity.
0 Comments2 Minutes
July 9, 2020
Therapixel receives FDA 510(k) clearance for MammoScreen™
AI-powered reading aid for screening mammography improves Radiologists’ performance in cancer detection
0 Comments3 Minutes